11.11
1.10%
-0.1211
전일 마감가:
$11.23
열려 있는:
$11.14
하루 거래량:
49,718
Relative Volume:
0.08
시가총액:
$768.33M
수익:
-
순이익/손실:
$-209.96M
주가수익비율:
-3.7404
EPS:
-2.97
순현금흐름:
$-176.27M
1주 성능:
-2.57%
1개월 성능:
-2.14%
6개월 성능:
+99.40%
1년 성능:
+6.49%
레플리뮨 Stock (REPL) Company Profile
명칭
Replimune Group Inc
전화
(781) 222-9600
주소
500 UNICORN PARK, WOBURN, MA
REPL을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
REPL | 11.14 | 768.33M | 0 | -209.96M | -176.27M | -2.97 |
VRTX | 447.58 | 115.74B | 10.63B | -479.80M | -1.35B | 13.33 |
REGN | 741.92 | 81.65B | 13.85B | 4.65B | 3.32B | 35.06 |
ARGX | 589.39 | 34.86B | 1.86B | -40.29M | -1.28B | -4.16 |
ALNY | 248.84 | 32.09B | 2.09B | -332.26M | 16.06M | -4.14 |
BNTX | 103.41 | 24.49B | 3.30B | -501.07M | 1.03B | 11.54 |
레플리뮨 Stock (REPL) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2023-04-17 | 재개 | Piper Sandler | Overweight |
2021-11-19 | 개시 | Piper Sandler | Overweight |
2021-10-15 | 재개 | BTIG Research | Buy |
2020-11-17 | 개시 | BTIG Research | Buy |
2020-11-02 | 개시 | Jefferies | Buy |
2020-10-15 | 업그레이드 | H.C. Wainwright | Neutral → Buy |
2020-07-01 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
2020-05-05 | 개시 | Barclays | Overweight |
2019-09-04 | 개시 | ROTH Capital | Buy |
2019-07-23 | 개시 | Chardan Capital Markets | Buy |
2019-07-12 | 업그레이드 | JP Morgan | Neutral → Overweight |
2019-07-08 | 개시 | H.C. Wainwright | Buy |
2019-04-25 | 개시 | Wedbush | Outperform |
2019-01-23 | 다운그레이드 | JP Morgan | Overweight → Neutral |
2018-08-14 | 개시 | JP Morgan | Overweight |
2018-08-14 | 개시 | Leerink Partners | Outperform |
모두보기
레플리뮨 주식(REPL)의 최신 뉴스
Replimune's chief commercial officer sells $56,131 in stock By Investing.com - Investing.com Nigeria
Replimune group's chief medical officer sells shares worth $78,111 By Investing.com - Investing.com Canada
Replimune's chief commercial officer sells $56,131 in stock - Investing.com
REPL (Replimune Group) Peter Lynch Fair Value : N/A (As of Nov. 20, 2024) - GuruFocus.com
Replimune Group, Inc. (NASDAQ:REPL) Shares Acquired by LMR Partners LLP - MarketBeat
Replimune Group Q3 EPS Forecast Decreased by Leerink Partnrs - Defense World
What is Wedbush's Estimate for Replimune Group Q3 Earnings? - MarketBeat
HC Wainwright Predicts Stronger Earnings for Replimune Group - MarketBeat
Leerink Partnrs Weighs in on Replimune Group Q3 Earnings - MarketBeat
Significant Stake Increase by Baker Bros. Advisors in Replimune Group Inc - GuruFocus.com
Brokerages Set Replimune Group, Inc. (NASDAQ:REPL) Target Price at $16.80 - Defense World
When (REPL) Moves Investors should Listen - Stock Traders Daily
Replimune Group’s Q3 2024 Financial Highlights - TipRanks
Replimune Group Inc. (REPL) Quarterly 10-Q Report - Quartzy
Replimune Group (NASDAQ:REPL) Receives Buy Rating from HC Wainwright - MarketBeat
Replimune Reports $432.1M Cash Position, Advances Melanoma Treatment BLA Plans | REPL Stock News - StockTitan
Replimune stock soars to 52-week high, touches $12.86 By Investing.com - Investing.com Australia
Analysts Set Replimune Group, Inc. (NASDAQ:REPL) Price Target at $16.80 - MarketBeat
Replimune stock soars to 52-week high, touches $12.86 - Investing.com India
Replimune Group (NASDAQ:REPL) Hits New 52-Week HighStill a Buy? - MarketBeat
Creative Planning Buys 4,699 Shares of Replimune Group, Inc. (NASDAQ:REPL) - Defense World
Replimune's RP1 Shows 33.6% Response Rate in Melanoma Trial, Marks Breakthrough | REPL Stock News - StockTitan
Replimune Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Replimune Group Awards Stock Options, RSUs to New Employees in Retention Move | REPL Stock News - StockTitan
TSX Consumer Staples Capped Index (TTCS) QuotePress Release - The Globe and Mail
KBW Bank Index (BKX) QuotePress Release - The Globe and Mail
Itron Inc (ITRI-Q) QuotePress Release - The Globe and Mail
Vanguard Group's Strategic Acquisition in Replimune Group Inc - GuruFocus.com
Teledyne Technologies Inc (TDY-N) QuotePress Release - The Globe and Mail
Replimune to Present at the 39th Annual Meeting of the Society for Immunotherapy of Cancer (SITC) - The Manila Times
Masco Corp (MAS-N) QuotePress Release - The Globe and Mail
Skechers U.S.A. (SKX-N) QuotePress Release - The Globe and Mail
S&P GSCI Index (GNX) QuotePress Release - The Globe and Mail
Non-melanoma Skin Cancer is Predicted to Exhibit Remarkable Growth During the Study Period (2020–2034) | DelveInsight - GlobeNewswire Inc.
SG Americas Securities LLC Invests $251,000 in Replimune Group, Inc. (NASDAQ:REPL) - Defense World
Replimune Group, Inc. (NASDAQ:REPL) Given Average Recommendation of "Buy" by Analysts - MarketBeat
It would be worthwhile to take a closer look at Replimune Group Inc (REPL) - US Post News
Daily Progress: Replimune Group Inc (REPL) Drop -7.06, Closing at 10.67 - The Dwinnex
Replimune Group Inc [REPL] Insider Selling: Time to sell? - Knox Daily
Replimune Group Inc Inc. (REPL) Price Performance: A Comparative Analysis with Competitors - The InvestChronicle
Replimune Group (NASDAQ:REPL) Stock Price Down 5.2%Here's What Happened - MarketBeat
Learn to Evaluate (REPL) using the Charts - Stock Traders Daily
Cubist Systematic Strategies LLC Buys 53,313 Shares of Replimune Group, Inc. (NASDAQ:REPL) - MarketBeat
Gaining Ground: Replimune Group Inc (REPL) Closes Higher at 11.74, Up 3.62 - The Dwinnex
Investing in Replimune Group Inc (REPL) Is Getting More Attractive - Knox Daily
Replimune Group, Inc. (NASDAQ:REPL) Shares Sold by Dimensional Fund Advisors LP - MarketBeat
Morgan Stanley's Strategic Reduction in Replimune Group Inc Holdings - GuruFocus.com
Cubist Systematic Strategies LLC Increases Position in Replimune Group, Inc. (NASDAQ:REPL) - Defense World
Replimune Group, Inc. (NASDAQ:REPL) Shares Purchased by Millennium Management LLC - MarketBeat
Chief Financial Officer Hill Emily Luisa sale 8,938 shares of Replimune Group Inc [REPL] - Knox Daily
Insiders At Replimune Group Sold US$863k In Stock, Alluding To Potential Weakness - Simply Wall St
레플리뮨 (REPL) 재무 분석
매출
순이익
현금흐름
주당 순 이익
레플리뮨 주식 (REPL) 내부자 거래
내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
---|---|---|---|---|---|---|---|
Sarchi Christopher | Chief Commercial Officer |
Nov 18 '24 |
Sale |
10.78 |
5,207 |
56,131 |
87,045 |
Hill Emily Luisa | Chief Financial Officer |
Aug 16 '24 |
Sale |
10.18 |
8,938 |
90,989 |
101,057 |
Xynos Konstantinos | Chief Medical Officer |
Jun 07 '24 |
Sale |
7.50 |
15,881 |
119,108 |
117,131 |
Sarchi Christopher | Chief Commercial Officer |
May 16 '24 |
Sale |
6.47 |
2,218 |
14,350 |
92,252 |
Schwendenman Andrew | Chief Accounting Officer |
May 16 '24 |
Sale |
6.47 |
2,298 |
14,868 |
38,238 |
Love Colin | Chief Operating Officer |
May 16 '24 |
Sale |
6.47 |
17,615 |
113,969 |
777,345 |
Astley-Sparke Philip | Executive Chairman |
May 16 '24 |
Sale |
6.47 |
37,928 |
245,394 |
1,487,350 |
Coffin Robert | Director |
May 16 '24 |
Sale |
6.47 |
11,464 |
74,172 |
1,821,872 |
Patel Sushil | Chief Executive Officer |
May 16 '24 |
Sale |
6.47 |
20,194 |
130,655 |
212,014 |
Xynos Konstantinos | Chief Medical Officer |
May 16 '24 |
Sale |
6.47 |
6,367 |
41,194 |
133,012 |
자본화:
|
볼륨(24시간):